Topera, Inc. today announced that its FDA-cleared and commercially available 3-D mapping system will be discussed in 14 scientific presentations at the 35th Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 7-10 in San Francisco, CA. Leading physicians from around the world will share new insights about their clinical data and long-term patient outcomes using the Company’s advanced rotor mapping technology.
Help employers find you! Check out all the jobs and post your resume.
